Listings (IPO)

The AI-driven underwriting firm seeks capital to ease liquidity pressure and convince investors of a viable path to profitability.

Years after its ChiNext debut, the medical device maker turns to Hong Kong’s market to fund its next expansion phase.

The proposed IPO would add to GEM’s Shenzhen and Swiss listings, with proceeds aimed at expansion and development.